Geode Capital Management’s iSpecimen ISPC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-7,827
Closed -$49.2K 4516
2026
Q1
$49.2K Buy
7,827
+6,787
+653% +$76.2K ﹤0.01% 4316
2025
Q4
$10.8K Sell
1,040
-2
-0.2% -$51 ﹤0.01% 4431
2025
Q3
$53.8K Buy
1,042
+672
+182% +$31.6K ﹤0.01% 4276
2025
Q2
$14.5K Buy
370
+102
+38% +$4.75K ﹤0.01% 4399
2025
Q1
$11.4K Buy
+268
New +$20.4K ﹤0.01% 4427
2024
Q3
Sell
-48
Closed -$11.9K 4559
2024
Q2
$11.9K Hold
48
﹤0.01% 4528
2024
Q1
$8.93K Hold
48
﹤0.01% 4561
2023
Q4
$19.3K Hold
48
﹤0.01% 4521
2023
Q3
$23.9K Buy
48
+21
+78% +$18.5K ﹤0.01% 4587
2023
Q2
$30.9K Hold
27
﹤0.01% 4595
2023
Q1
$29.2K Hold
27
﹤0.01% 4637
2022
Q4
$29K Hold
27
﹤0.01% 4711
2022
Q3
$35K Sell
27
-2
-7% -$3.58K ﹤0.01% 4825
2022
Q2
$50K Buy
29
+2
+7% +$4.89K ﹤0.01% 4773
2022
Q1
$115K Buy
27
+10
+59% +$39.1K ﹤0.01% 4612
2021
Q4
$103K Buy
+17
New +$122K ﹤0.01% 4722

Other funds holding ISPC

Geode Capital Management's ISPC Position: Q2 2026 in Review

Geode Capital Management sold out of iSpecimen (ISPC) in Q2 2026, closing a stake of 7,827 shares — an estimated $49.2K sold.

Geode Capital Management first reported a position in ISPC in Q4 2021 and held it in 16 quarters. The position peaked at $115K in Q1 2022. 8 funds tracked by Wall St. Rank hold ISPC as of Q2 2026.

  • Geode Capital Management reported no remaining iSpecimen position as of Q2 2026 after selling out during the quarter.
  • Geode Capital Management sold 7,827 iSpecimen shares in Q2 2026, an estimated $49.2K.
  • Geode Capital Management first reported a position in iSpecimen in Q4 2021 and held it in 16 quarters.
  • Geode Capital Management's iSpecimen position peaked at $115K in Q1 2022.
  • 8 funds tracked by Wall St. Rank held iSpecimen as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.